Biotech · Private company
Sequence LifeScience, Inc.
Track this companyFree. Adds Sequence LifeScience, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- Activate™ MatrixDiabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Activate™ Matrix + SOCSkin UlcerClinicalTrials.gov · fetched Nov 12, 2026
- AmnioDefend™ FT MatrixDiabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- AmnioDefend™ FT Matrix + SOCSkin UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Enclose™ TL MatrixDiabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Palisade™ DM MatrixDiabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Palisade™ DM Matrix + SOCSkin UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Sentry™ SL MatrixDiabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Sentry™ SL Matrix + SOCSkin UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Shelter™ DM Matrix + SOCDiabetic Foot UlcerClinicalTrials.gov · fetched Nov 12, 2026
- Shelter™ DM Matrix + SOCSkin UlcerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.PHASE4 · RECRUITING · started Jan 28, 2026ClinicalTrials.gov NCT07665268 · fetched Nov 12, 2026
- Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound TherapyPHASE4 · RECRUITING · started Jul 11, 2025ClinicalTrials.gov NCT07086443 · fetched Nov 12, 2026